Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 8 clinical trials
PCSK9 Inhibitor Treatment for Patients With SPG5

Spastic paraplegia type 5 (SPG5) is a rare subtype of hereditary spastic paraplegia, a highly heterogeneous group of neurodegenerative disorders defined by progressive neurodegeneration of the

  • 9 views
  • 30 Nov, 2021
  • 1 location
The Pre-SPG4 Study

Study goals Prospective longitudinal data on progression in the natural course of SPG4 in presymptomatic mutation carriers prior to clinical disease onset and in early stages of disease Biomarkers providing objective measures of disease activity

  • 15 views
  • 07 Oct, 2021
  • 2 locations
Phenotypes Biomarkers and Pathophysiology in Hereditary Spastic Paraplegias and Related Disorders

The aim of this study is to determine the clinical spectrum and natural progression of Hereditary Spastic Paraplegias (HSP) and related disorders in a prospective multicenter natural history

  • 8 views
  • 31 May, 2021
  • 15 locations
Genetic and Physical Study of Childhood Nerve and Muscle Disorders

Background Some nerve and muscle disorders that start early in life (before age 25), like some forms of muscular dystrophy, can run in families. However, the genetic causes of these disorders are not known. Also, doctors do not fully understand how symptoms of these disorders change over time. Researchers want …

Accepts healthy volunteers
myopathy
x-rays
  • 52 views
  • 16 Jan, 2022
  • 1 location
Swiss Cerebral Palsy Registry

The Swiss-CP-Reg is a national patient registry that collects information on diagnosis, symptoms, treatment and follow-up of patients with cerebral palsy (CP) in Switzerland. It was first implemented in 2017 in the paediatric clinics in Basel, Bellinzona, Bern, Geneva, Lausanne, St. Gallen and Zurich. It will be extended to all …

  • 0 views
  • 11 Aug, 2021
  • 8 locations
Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia

The Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia (HSP) is focused on gathering longitudinal clinical data as well as biological samples (skin and/or blood and

Accepts healthy volunteers
  • 0 views
  • 24 Nov, 2021
  • 1 location
A Registered Cohort Study on Spastic Paraplegia

The aim of this study is to determine the clinical spectrum and natural progression of Hereditary Spastic Paraplegias(HSP) and related disorders in a prospective multicenter natural history

  • 0 views
  • 23 Jan, 2021
  • 1 location
Phenotype, Genotype and Biomarkers 2 (PGB2)

sclerosis (PLS), hereditary spastic paraplegia (HSP), progressive muscular atrophy (PMA) and multisystem proteinopathy (MSP). More precisely, the investigator wants to identify the links that exist between

primary lateral sclerosis
hereditary spastic paraplegia
atrophy
amyotrophic lateral sclerosis
dementia
  • 0 views
  • 25 Jan, 2022
  • 1 location